Xylem IncNYSE: XYL
Industrials · Industrial Machinery & Supplies & Components
$111.40
+1.00%
Vol: 1.3M
Research Digest
Friday, June 19, 2026
Xylem expands Dow partnership for industrial water system in Canada and completes sale of international Sensus metering business, while stock remains down 20% year-to-date.
On June 8, 2026, Xylem (NYSE: XYL) announced an expansion of its long-standing partnership with Dow to design, build, and operate advanced water systems at Dow's Path2Zero industrial complex in Fort Saskatchewan, Alberta, Canada — a full water-cycle project expected to be operational by August 2028. Xylem also completed the sale of its international Sensus metering business (Sensus International) to AURELIUS on May 26, 2026, retaining the North America Sensus operations. The company updated its 2026 revenue guidance to $9.2-$9.3 billion (up 2-3% reported, vs. prior 1-3%), and declared a Q2 dividend of $0.43/share payable June 25. Despite these positive developments, XYL shares are down approximately 20.5% year-to-date and 13.2% over one year, trading near $111-$113, with the Dow deal cited as a potential catalyst for revaluation.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14Xylem shares back in focus on long-term Dow water-system deal as the stock trades near year lows.Positive▶
Xylem (XYL) is back in focus after agreeing to design, build, and operate a full-cycle advanced water system at Dow's large-scale industrial complex in Fort Saskatchewan, Alberta, Canada, with the system expected to be operational by August 2028. The long-term build-own-operate arrangement is being read by some analysts as a recurring-revenue catalyst supporting an undervaluation thesis after a weak stretch for the shares. On June 14, 2026, XYL traded between roughly $108.80 and $110.41, near a market cap of about $26.2B, with the stock down about 20.5% year-to-date and a one-year total shareholder return of about -13.2%. The average analyst price target sits around $169 (range $130 to $182), implying significant upside versus the depressed price. The bear case is that the Alberta system does not contribute until 2028, so near-term financials are unchanged while broad industrial/water demand softness, portfolio divestitures (e.g., AURELIUS buying the international metering division), and multiple compression continue to weigh on the stock.
May 21Xylem directors purchased $400K of stock May 14 signaling insider confidence amid 2026 outlook revisionPositive▶
Xylem directors Jerome Peribere and Mark Morelli each acquired 1,711 shares ($400K total) at $116.88 on May 14, the same day shareholders re-elected the nine-member board, ratified Deloitte as auditor, and approved the 2026 Employee Stock Purchase Plan. Earlier, Peribere bought 1,210 shares at $116.61 on May 4. The Board declared a $0.43 Q2 dividend payable June 25 (record date May 28). Stock traded $106-108 on May 20. The company revised full-year revenue guidance upward (+2-3% growth) following a Q1 EPS beat ($1.12 vs $1.09). Risk: insider sell from CAO Geri-Michelle McShane (3,147 shares at $86.76 on May 7) cuts against the directors bullish signal.
May 20Xylem shareholders approved board and 2026 ESPP at May 14 annual meeting with insider buys of $400K signaling director confidencePositive▶
Xylem held its 2026 Annual Meeting on May 14, 2026 with 88.12% of outstanding shares represented. Shareholders elected nine directors to one-year terms, ratified Deloitte & Touche as independent auditor, approved executive compensation on an advisory basis, and endorsed the 2026 Employee Stock Purchase Plan. Insider activity was notable: on May 14, directors Jerome Peribere and Mark Morelli each bought 1,711 shares (3,422 total worth ~$400K at $116.88). Earlier, Peribere also purchased 1,210 shares on May 4 at $116.61. Officer Geri-Michelle McShane sold 3,147 shares on May 7 at $86.76. Shares traded near $106 on May 20. Analyst consensus remains Buy with the most recent rating a Hold at $135 price target.
May 19No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 18Xylem director Peribere bought 1,210 shares at $116.61 on May 4 while CAO McShane sold 3,147 shares at $86.76 on May 7; Q1 EPS rose 14% with FY26 revenue view lifted.Mixed▶
Xylem saw notable insider activity in early May: Director Jerome Peribere purchased 1,210 shares at $116.61 on May 4 (~$141K, raising his stake to 27,209 shares), while Senior VP and Chief Administrative Officer Geri-Michelle McShane sold 3,147 shares at $86.76 on May 7. Q1 2026 results showed adjusted EPS of $1.12 (up 14%) with net income of $193M and orders of $2.2B. The company raised its 2026 revenue guidance to $9.2-$9.3B and provided Q2 guidance of 2-3% reported revenue growth with EPS of $1.31-$1.36. Xylem participated in the Oppenheimer 21st Annual Industrial Growth Conference on May 7. Shares traded around $109.45 on May 13, down 21.1% YTD, with DCF analysis suggesting 31.8% undervaluation versus intrinsic value of $158.50.
May 15Xylem trading near $109 with insider activity split: director bought $141K on May 4 vs. SVP sold $273K on May 7Mixed▶
Xylem trading around $109.45 on May 13 within a 52-week range of $108.97-$154.27. Insider activity was mixed: director Jerome Peribere purchased 1,210 shares at $116.61 on May 4 (signal of confidence at a depressed price), while Chief Administrative Officer Geri-Michelle McShane sold 3,147 shares at $86.76 on May 7 in an M-Exempt transaction. The moves follow Q1 2026 results where adjusted EPS reached $1.12 with net income of $193M and $2.2B in orders; Xylem now sees 2026 revenue of $9.2-9.3B and adjusted EPS of $5.35-$5.60. Xylem will present at the Oppenheimer 21st Annual Industrial Growth Conference. Sell-side remains constructive with 14 Buy ratings and roughly 37.8% upside to consensus targets.
May 14Xylem director Peribere bought 1,210 shares at $116.61 on May 4 while CAO McShane sold 3,147 at $86.76 on May 7Mixed▶
Director Jerome Peribere acquired 1,210 Xylem shares at $116.61 on May 4 (~$141K) signaling insider confidence, while CAO Geri-Michelle McShane sold 3,147 shares at $86.76 on May 7. Xylem Q1 2026 EPS of $1.12 beat $1.09 estimate; revenue $2.13B slightly missed $2.11B forecast. Full-year revenue guide was raised to $9.2B-$9.3B. JPMorgan reaffirmed Buy on May 1. Stock at $109.45 on May 13, with consensus rating of Buy from 14 analysts.
May 13No significant overnight updatesNeutral▶
No material news in last 48 hours.
May 12Xylem CAO Geri-Michelle McShane sold 3,147 shares at $86.76 on May 7, while director Jerome Peribere bought 1,210 shares at $116.61 on May 4, sending mixed insider signals.Mixed▶
Xylem saw mixed insider activity in early May, with director Jerome Peribere acquiring 1,210 shares at $116.61 on May 4 while SVP/CAO Geri-Michelle McShane sold 3,147 shares at $86.76 on May 7. The water technology company had reported strong Q1 2026 results on April 28 with EPS of $1.12 beating $1.09 consensus and revenue of $2.13 billion. Xylem raised its 2026 revenue guidance to $9.2-$9.3 billion. JPMorgan reaffirmed its Buy rating May 1 while Mizuho maintained Hold April 30. Shares trade around $112.37 with the stock up about 5% on the week despite a wider 90-day decline of 16.3%. Risk: insider selling and stock weakness over the past quarter could weigh on near-term sentiment.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| PHPARKER | $955.22 | +0.98% | +0.2% | 28.2x | 1.11 | $121.4B |
| ITWILLINOIS | $264.30 | +0.84% | +3.4% | 22.4x | 1.01 | $78.5B |
| GWWWW | $1,362.85 | +3.95% | +0.0% | 26.6x | 1.03 | $63.4B |
| IRINGERSOLL | $78.13 | +1.38% | +2.9% | 20.9x | 1.17 | $31.5B |
| DOVDOVER | $223.88 | +1.40% | -4.7% | 18.5x | 1.16 | $28.8B |
| XYLXYLEM | $111.40 | +1.00% | +5.4% | 19.4x | 1.02 | $28.1B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price below 200d MA — bearish structure.